Mechanical thrombectomy in stroke patients of advanced age with score-based prediction of outcome

医学 改良兰金量表 置信区间 优势比 冲程(发动机) 内科学 缺血性中风 机械工程 工程类 缺血
作者
Nicolaj Grønbæk Laugesen,Andreas Hjelm Brandt,Trine Stavngaard,Joan Højgaard,Klaus Hansen,Thomas Truelsen
出处
期刊:Interventional Neuroradiology [SAGE Publishing]
卷期号:: 159101992211490-159101992211490 被引量:4
标识
DOI:10.1177/15910199221149073
摘要

Background Stroke patients ≥80 years constituted only 15% in randomised trials on mechanical thrombectomy (MT), but is a considerable higher proportion in clinical practice. Association of clinical variables collected before MT with functional outcome has not been independently described in these patients, while being important in the decision of patient eligibility for MT. Methods We included patients consecutively at a single centre (2017–2021) categorised as octogenarians (age: 80–89 years) or nonagenarians (age: 90–99 years). Functional outcome at 90 days was defined as fair (modified Rankin Scale (mRS) 0–3) or poor (mRS 4–6). Clinical variables collected before MT were analysed for association with shift of mRS in a poor direction. Significant predictors were used to produce a risk score of fair outcome. Significance was set at the p < 0.05 level. Results Nonagenarians (n = 43, 15.5%) compared to octogenarians (n = 235, 84.5%) less likely achieved fair outcome (20.9% vs. 46.0%, p < 0.01) with higher mortality (65.1% vs. 31.9%, p < 0.01). Significant predictors of outcome were: age, adjusted odds ratio (aOR) = 0.91 (95% confidence interval (CI): 0.86–0.97); pre-stroke mRS, aOR = 0.57 (95% CI: 0.44–0.73); National Institute of Health Stroke Scale at admission, aOR = 0.91 (95% CI: 0.87–0.95); Alberta Stroke Program Early Computed Tomography, aOR = 1.23 (95% CI: 1.05–1.45). After bootstrap validation, the area under the curve of the risk score was 0.74 and the optimal cut-off for fair outcome was a score of >7 points. Conclusions One in two octogenarians achieved fair outcome, however, only one in five nonagenarians had fair outcome. The clinical risk score could be considered as guidance when deciding patient eligibility for MT.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
bill完成签到,获得积分10
刚刚
刚刚
隐形幻露完成签到,获得积分10
1秒前
xcc完成签到,获得积分10
1秒前
碎片完成签到,获得积分10
1秒前
1秒前
不想做实验完成签到,获得积分10
1秒前
Rei发布了新的文献求助10
1秒前
ghmghm9910完成签到 ,获得积分10
2秒前
suzhenyue发布了新的文献求助10
2秒前
LAN完成签到,获得积分10
3秒前
勤恳绝施发布了新的文献求助10
3秒前
干净的绿真完成签到 ,获得积分10
4秒前
Ashes完成签到,获得积分10
4秒前
角鸮完成签到,获得积分0
4秒前
伊祁夜明完成签到,获得积分10
6秒前
WZ完成签到 ,获得积分10
6秒前
Lidanni完成签到 ,获得积分10
6秒前
执着的似狮完成签到,获得积分10
8秒前
cc完成签到,获得积分10
8秒前
DuesKing完成签到,获得积分10
8秒前
米米完成签到,获得积分10
8秒前
wzxwzx发布了新的文献求助10
8秒前
刘哔完成签到,获得积分10
8秒前
9秒前
Fengzhen007完成签到,获得积分10
9秒前
lzx完成签到,获得积分10
9秒前
闪电侠完成签到,获得积分10
9秒前
9秒前
温暖富完成签到,获得积分10
10秒前
邹栗完成签到 ,获得积分10
10秒前
斯奈克完成签到,获得积分20
11秒前
sougardenist完成签到 ,获得积分10
11秒前
cdercder应助唠叨的夏烟采纳,获得10
11秒前
烟消云散应助YangSY采纳,获得10
11秒前
12秒前
哈哈发布了新的文献求助10
12秒前
lu2025完成签到,获得积分10
12秒前
小小脑袋大大灵光完成签到 ,获得积分10
13秒前
CanLiu完成签到,获得积分10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
University Physics for the Life Sciences 500
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6951786
求助须知:如何正确求助?哪些是违规求助? 8636020
关于积分的说明 18311955
捐赠科研通 6394399
什么是DOI,文献DOI怎么找? 3082215
关于科研通互助平台的介绍 2127533
邀请新用户注册赠送积分活动 2059101